Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) NHS Subsidiary Partners with HelloMD to Expand Patient Reach, Offer Enhanced Medical Cannabis Services

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced the partnership between its wholly owned subsidiary, Natural Health Services Ltd. (“NHS”), and HelloMD, a leading online cannabis telehealth company, to extend telemedicine services to its patients and provide more Canadian communities with convenient access to medical cannabis advice. According to the update, HelloMD will provide its turnkey white-label services to NHS, providing existing and future patients with online health care practitioner consultation services. NHS currently operates a network of seven medical cannabis clinics in four provinces, and the new option will allow the company to extend its services to areas where there are not existing clinics, reduce wait times and offer the convenience of evening and weekend consultations. “Partnering with HelloMD enhances the NHS mission to improve the way Canadians access safe, regulated medical cannabis and education on how to use cannabis to improve health and quality of life,” NHS Medical Director and Interim President Dr. Mark Kimmins stated in the news release. “By utilizing the telehealth expertise of HelloMD, we will be able to increase our patient base and serve the needs of more Canadians.”

To view the full press release, visit

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Its ability to leverage large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through its strategically positioned cultivation and extraction facilities, Sunniva intends to launch a suite of branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, and extracts while expanding upstream opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in MissionIRNewsBreaks, Sunniva Inc. SNNVF. Bookmark the permalink.

Comments are closed.